Eicosanoids & Vascular Pharmacology

Human vascular tissue research
Welcome to our homepage, enjoy your visit!

This website is certified by Health On the Net Foundation. Click to verify.

Host laboratory for BA, Master and PhD Thesis, contact: xnorel@hotmail.com,  INSERM U1148, Laboratory for Vascular Translational Science (LVTS). CHU X. Bichat, 46, rue Henri Huchard, 75877 Paris Cedex 18, France. Access, map. Tel: 33 1 40 25 75 29, Fax: 33 1 40 25 86 02.
We comply with the HONcode standard for trustworthy health information: verify here. Webmasters: X. Norel (PhD). ©2018-2021 Eicosanoids & Vasc. Pharmacol. about the website
Last update: 14/06/18

Laboratory & Links

holinergic control in the human pulmonary vessels

Muscarinic receptor in the human vessels and PGI2 release

Results in isolated human pulmonary arteries (HPA) support the notion that the ACh-induced contraction involves only M3 receptors on the smooth muscle, whereas activations of M3 and M1 receptors on the endothelium produce relaxation (Norel et al., Br. J. Pharmacol., 1996). In human pulmonary veins (HPV), no contraction is induced by ACh and the activation of M1 receptors on the endothelium produces relaxation (Walch et al., Br. J. Pharmacol., 2000).

HPA are more sensitive to the relaxant effect of ACh than human pulmonary veins (Walch et al., Br. J. Pharmacol., 1997). Measurements of 6-keto-PGF1a, the stable metabolite of PGI2 , after a challenge with ACh suggest that this difference could be partly explained by a greater release of PGI2 by HPA versus HPV (Walch et al., J. Physiol. Paris, 1998).